CAELUM BIOSCIENCES
Live / Registered — Registered (as of 21 Apr 2020)
What this means for you
Registered since 21 Apr 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87982774
- Registration number
- 6037766
- Mark type
- Stylized text
- Filed
- 12 Jan 2017
- Published for opposition
- 05 Dec 2017
- Registered
- 21 Apr 2020
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 042 — Scientific and technological services: Biochemical research and development; Biological research; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical research services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research services; Scientific research consulting in the field of amyloidosis and diseases where amyloid deposits are present; Scientific research consulting in the field of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, progressive organ disease and failure; Scientific research consulting in the field of serious and life threatening diseases; Scientific research for medical purposes in the field of amyloidosis and diseases where amyloid deposits are present; Scientific research for medical purposes in the field of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, progressive organ disease and failure; Scientific research for medical purposes in the field of serious and life threatening diseases; Research in the field of pharmacogenetics; Conducting clinical trials for others in the field of pharmaceuticals; Research services in the field of proteins, antibodies, microorganisms and cells; Research and development services in the field of antibody technology; Structural and functional analysis of genomes; DNA screening for scientific research purposes; Biochemical research and analysis; research and development services in the field of immunology
Owner
- Caelum Biosciences, Inc., New York, NY, US
- Caelum Biosciences, Inc., New York, NY, US
- Caelum Biosciences, Inc., New York, NY, US
Prosecution history
- 21 Apr 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Mar 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 18 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Apr 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Apr 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Oct 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Oct 2021 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 26 Oct 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Oct 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Apr 2020 — REGISTERED-PRINCIPAL REGISTER
- 17 Mar 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Mar 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED